Aceclora Tablet 100 mg

Aceclora Tablet is a widely prescribed NSAID containing Aceclofenac 100 mg. Manufactured by Marksman Pharmaceuticals Ltd, this film-coated tablet effectively treats osteoarthritis, rheumatoid arthritis, and acute pain conditions. Priced at ৳3.02 per unit, it offers affordable therapy with a 50’s pack available for ৳151.00.

As a cyclooxygenase inhibitor, Aceclora reduces inflammation by blocking prostaglandin synthesis. Clinical studies show rapid absorption post-administration, making it suitable for dental pain, ankylosing spondylitis, and lower back pain management. Patients should follow dosage guidelines carefully to minimize side effects.

The recommended dosage varies by formulation:

• Extended-release: 200 mg once daily
• Film-coated: 100 mg twice daily

Always consult physicians before combining with diuretics, anticoagulants, or lithium to avoid drug interactions.

Common side effects include mild dyspepsia (12-15% users) and transient skin reactions. Pregnant women should avoid Aceclora unless benefits outweigh fetal risks. Store tablets in dry conditions below 30°C, away from children. For alternative NSAID options, explore tablet formulations with similar efficacy profiles.

Adult Dose: Film-coated: 100 mg twice daily. Extended-release: 200 mg once daily. Adjust dose in renal/hepatic impairment. Take with food. Maximum 10 days without medical supervision.

Aceclora is a non-steroidal drug with anti-inflammatory and analgesic properties. It is a potent inhibitor of the enzyme cyclooxygenase, which is involved in the production of prostaglandin. After oral administration, it is rapidly and completely absorbed an unchanged drug.

Pregnancy Category D. Contraindicated in third trimester. Avoid during lactation due to potential infant risks.

Monitor ECG and renal function in elderly ≥60 years, chronic kidney disease patients. Perform liver tests during long-term therapy.

Pediatric safety unestablished. Reduce dose by 50% in elderly. Contraindicated in severe renal impairment (eGFR <30). Double dosing interval in hepatic cirrhosis.